STUDIES ON BIOFILM INHIBITION AND ANTIMICROBIAL RESISTANCE IN S. aureus AND STREPTOCOCCUS SPECIES CAUSING BOVINE MASTITIS
| dc.contributor.advisor | RAMANI PUSHPA, R.N.(MAJOR) | |
| dc.contributor.advisor | LAKSHMI KAVITHA, K | |
| dc.contributor.advisor | SRINIVASA RAO, T | |
| dc.contributor.author | JOSEPH, GREESHMA ANN | |
| dc.date.accessioned | 2019-07-06T09:20:39Z | |
| dc.date.available | 2019-07-06T09:20:39Z | |
| dc.date.issued | 2018-12 | |
| dc.description | THESES | en_US |
| dc.description.abstract | Bovine mastitis is recognised as the most economically important disease affecting Dairy industry in India and all over the world. Most prevalent bacterial etiological agents identified in bovine mastitis are Staphylococcus aureus, Streptococcus species, E. coli and other Gram-negative organisms. The preferred treatment regime during the past decades for mastitis is antibiotic therapy. The associated antimicrobial resistance and recurrent infections caused by slime producing bacteria is the major constraint. The time has elapsed to think about new treatment methods and agents. Hence the present study is on the biofilm forming S. aureus and Streptococcus species causing bovine mastitis and the effect of antibiofilm agents on the antimicrobial resistance of the microorganisms. A total of 91 Bovine mastitic milk samples were examined and out of this 75 (82.41 %) samples were positive for S. aureus and Streptococcus species. A total of 110 isolates were obtained, the prevalence observed was S. aureus 62 (56.36%), other Staphylococci 2 (1.81%), S. uberis 44 (40%) and other Streptococci 2 (1.81%). All S. aureus and Streptococcus species isolates were confirmed by genus specific PCR followed by species specific PCR. Two Streptococcus isolates did not react to any of the specific primers used for S. uberis, S. agalactiae and S. dysgalactiae. Biofilm formation was detected using qualitative Congo red agar method (CRA), quantitative microtiter plate (MTP) assay and biofilm gene was detected using PCR. On CRA method 88.71% S. aureus isolates and on MTP assay 98.39 % isolates were biofilm producers. The ica locus was detected in 93.54% of the S. aureus isolates. The icaA gene was detected in 87.09% isolates and icaD was detected in 40 isolates. Fifty eight percent were carrying both icaA and icaD genes. On CRA 80.43% Streptococcus species isolates and on MTP assay 84.78% were biofilm producers. Among S. uberis isolates 34.09% were positive for the biofilm gene luxS by PCR. Twenty four isolates without luxS gene also produced very weak or moderate biofilm. On antibiotic sensitivity test the S. aureus isolates were resistant to Penicillin G, Ampicillin, Erythromycin, Methicillin, Clindamycin, Amoxycillin/Clavulanic acid, Streptomycin and were least resistant to Gentamicin, Cotrimoxazole, Chloramphenicol, Tetracycline and Vancomycin. All MRSA isolates were found to be biofilm producers while 96.87 % of MSSA were biofilm producers. MRSA was showing 2 to 4 times more resistance to all tested antibiotics than MSSA. The Streptococcus species showed high resistance to Ceftriaxone followed by Streptomycin, Erythromycin, Penicillin G, Tetracycline, Enrofloxacin, Amoxycillin/Clavulanic acid and least resistance to Gentamicin, Chloramphenicol and Ampicillin/ Sulbactam. Biofilm forming isolates were highly resistant to Ceftriaxone (66.66%), Streptomycin (41.02%), Erythromycin (38.46%), Tetracycline (33.33%) and Penicillin G (30.76%), whereas non biofilm formers showed considerably low resistance to Ceftriaxone (28.57%), Penicillin G (14.28%), Streptomycin (14.28%) and were 100% sensitive to all other antibiotics used. Biofilm inhibition studies were conducted in biofilm producing S. aureus and Streptococcus species identified by MTP. The mean±SE values of inhibition rates by 30 μg /ml Ursolic acid (UA), 100 μg /ml UA, 30 μg /ml resveratrol and 100 μg/ml resveratrol on 26 S. aureus isolates were found to be 40.67±4.64%, 62.03±3.61%, 37.38±4.86% and 53.66±4.25% respectively. Inhibition rates of antibiofilm agents on MSSA were found to be higher than MRSA except for the isolates treated with resveratrol 100 μg /ml concentration. Biofilm inhibition studies were conducted in 31 Streptococcus isolates. The mean±SE values of inhibition rates by 30 μg /ml UA, 100 μg /ml UA, 30 μg /ml resveratrol, 100 μg /ml resveratrol was 33.96±3.17%, 57.40±2.8%, 31.35±3.12% and 46.28±3.47%, respectively. Also, antimicrobial resistance of the isolates treated with antibiofilm agents at concentrations of 100 μg /ml UA and 100 μg /ml resveratrol for 18h was found to be decreased by at least 50% for each antibiotic. | en_US |
| dc.identifier.uri | http://krishikosh.egranth.ac.in/handle/1/5810113152 | |
| dc.keywords | BOVINE MASTITIS;STREPTOCOCCUS SPECIES;BIOFILM INHIBITION;ANTIMICROBIAL RESISTANCE;S. aureus | en_US |
| dc.language.iso | en | en_US |
| dc.pages | 177 | en_US |
| dc.publisher | SRI VENKATESWARA VETERINARY UNIVERSITY TIRUPATI - 517502. (A.P.) INDIA | en_US |
| dc.sub | Veterinary Microbiology | en_US |
| dc.subject | null | en_US |
| dc.theme | STUDIES ON BIOFILM INHIBITION AND ANTIMICROBIAL RESISTANCE IN S. aureus AND STREPTOCOCCUS SPECIES CAUSING BOVINE MASTITIS | en_US |
| dc.these.type | M.V.Sc. | en_US |
| dc.title | STUDIES ON BIOFILM INHIBITION AND ANTIMICROBIAL RESISTANCE IN S. aureus AND STREPTOCOCCUS SPECIES CAUSING BOVINE MASTITIS | en_US |
| dc.type | Thesis | en_US |